chr5-34929869-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001012339.3(DNAJC21):āc.50A>Gā(p.Glu17Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00016 in 1,573,004 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000086 ( 0 hom., cov: 29)
Exomes š: 0.00017 ( 4 hom. )
Consequence
DNAJC21
NM_001012339.3 missense
NM_001012339.3 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.04
Genes affected
DNAJC21 (HGNC:27030): (DnaJ heat shock protein family (Hsp40) member C21) This gene encodes a member of the DNAJ heat shock protein 40 family of proteins that is characterized by two N-terminal tetratricopeptide repeat domains and a C-terminal DNAJ domain. This protein binds the precursor 45S ribosomal RNA and may be involved in early nuclear ribosomal RNA biogenesis and maturation of the 60S ribosomal subunit. Mutations in this gene result in Bone marrow failure syndrome 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012968004).
BP6
Variant 5-34929869-A-G is Benign according to our data. Variant chr5-34929869-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 798856.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000859 (13/151264) while in subpopulation EAS AF= 0.00258 (13/5036). AF 95% confidence interval is 0.00153. There are 0 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC21 | NM_001012339.3 | c.50A>G | p.Glu17Gly | missense_variant | 1/12 | ENST00000648817.1 | NP_001012339.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC21 | ENST00000648817.1 | c.50A>G | p.Glu17Gly | missense_variant | 1/12 | NM_001012339.3 | ENSP00000497410 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000860 AC: 13AN: 151146Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
13
AN:
151146
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000191 AC: 42AN: 219976Hom.: 0 AF XY: 0.000133 AC XY: 16AN XY: 120714
GnomAD3 exomes
AF:
AC:
42
AN:
219976
Hom.:
AF XY:
AC XY:
16
AN XY:
120714
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000167 AC: 238AN: 1421740Hom.: 4 Cov.: 31 AF XY: 0.000160 AC XY: 113AN XY: 707522
GnomAD4 exome
AF:
AC:
238
AN:
1421740
Hom.:
Cov.:
31
AF XY:
AC XY:
113
AN XY:
707522
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000859 AC: 13AN: 151264Hom.: 0 Cov.: 29 AF XY: 0.0000947 AC XY: 7AN XY: 73920
GnomAD4 genome
AF:
AC:
13
AN:
151264
Hom.:
Cov.:
29
AF XY:
AC XY:
7
AN XY:
73920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
30
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 24, 2022 | DNA sequence analysis of the DNAJC21 gene demonstrated a sequence change, c.50A>G, in exon 1 that results in an amino acid change, p.Glu17Gly. This sequence change does not appear to have been previously described in individuals with DNAJC21-related disorders. This sequence change has been described in the gnomAD database with a frequency of of 0.26% in the East Asian subpopulation and an overall frequency of 0.018% (dbSNP rs761693334). The p.Glu17Gly change affects a moderately conserved amino acid residue located in a domain of the DNAJC21 protein that is known to be functional. The p.Glu17Gly substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Glu17Gly change remains unknown at this time. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
.;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;D;.
REVEL
Benign
Sift
Benign
.;T;T;.
Sift4G
Benign
.;T;T;.
Polyphen
B;B;B;.
Vest4
0.19, 0.20
MVP
0.32
MPC
0.068
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at